Tumor blood flow measured by perfusion computed tomography and 15O-labeled water positron emission tomography: a comparison study

J Comput Assist Tomogr. 2009 May-Jun;33(3):460-5. doi: 10.1097/RCT.0b013e318182d2e0.

Abstract

Objectives: To compare blood flow measurements of tumors assessed by perfusion computed tomography (pCT) and the clinical gold standard of 15O-labeled water positron emission tomography (15O-PET).

Methods: Blood flows were estimated by pCT (4-row multidetector, CT Perfusion 3.1) and 15O-PET (Posicam, first-pass model) in 14 patients with solid tumors, totaling 22 index tumors and 57 matched pairs of examinations. Blood flow estimates were compared using t test, Bland-Altman, and linear mixed regression analyses.

Results: There was no significant difference between the mean (SD) blood flow values measured by pCT and 15O-PET: 25.9 +/- 15.4 and 27.8 +/- 14.0 mL/min per 100 g, respectively.

Conclusions: The demonstration of a good correlation between pCT and 15O-PET potentially enables the use of pCT, which is more widely available than 15O-PET, when tumor blood flow estimates are required, particularly in the context of clinical studies.

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use
  • Blood Flow Velocity
  • Female
  • Humans
  • Isotope Labeling
  • Male
  • Middle Aged
  • Neoplasms / diagnosis*
  • Neoplasms / drug therapy
  • Neovascularization, Pathologic / diagnosis*
  • Neovascularization, Pathologic / prevention & control
  • Oxygen Radioisotopes*
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed / methods*
  • Water*

Substances

  • Antineoplastic Agents
  • Oxygen Radioisotopes
  • Radiopharmaceuticals
  • Water